Hosted on MSN

Bausch + Lomb publishes results from Xiidra 5% study

Bausch + Lomb (BLCO) announced Clinical Ophthalmology has published results from an investigator-initiated study which evaluated the effectiveness of Xiidra 5% in alleviating end-of-day eye dryness ...
Seeking Alpha

Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers

XIIDRA significantly improved end-of-day eye dryness and discomfort and delivered longer comfortable contact lens wear time in as little as two weeks Continued use further improved discomfort ...
Hosted on MSN

Bausch + Lomb’s XIIDRA Shows Promising Results for Contact Lens Wearers

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bausch + Lomb Corporation ( (BLCO)) just ...